Market Report: Barclays up again on Abu Dhabi backing

After a brief wobble in the morning, the FTSE 100 recorded its fourth day of gains, shrugging off some disappointing public finance data.

Barclays was once again a strong riser – it is up 18 per cent this week – still flying after announcing record profits on Tuesday, and helped by activity in the stock after the previous session's close. It was bolstered as Abu Dhabi investment group PCP3 exercised warrants bought during Barclays' fund raising in 2008 and took its stake to 5.2 per cent. The shares rose 6p to 308.3p.

The banks had started the day down, as had the miners, dragging the top tier briefly into the red. Yet sentiment shifted, sending the index up 48.45 points to 5,325. The miners returned to form before lunch on positive news announcements. Top sector riser was Eurasian Natural Resources Corporation, the Kazakhstan copper and iron ore giant, which announced it had bought a Zambian metals processing plant in a deal $300m (£192m). The move to buy Chambishi was made in part to cut costs by processing copper and cobalt dug out of mines in nearby Democratic Republic of Congo. The stock rose 31p to 1037p. It was followed up by rival Kazakhmys, which announced it was to put £1bn into a power plant it owns with the state welfare fund. It rose 38p to 1349p.

Top of the day was defence group BAE Systems, which posted its full-year results in the morning. The group met expectations, before buoying investor sentiment by saying it expects to boost its sales this year, then raised its dividend and announced the launch of a £500m share buyback scheme in 2010. Shareholders shrugged off the recent fine that settled its corruption investigation as well as the £973m impairments that dragged the company into a loss. The shares closed up 15p to 364p.

Another strong riser was consumer goods company Reckitt Benckiser Group, after support from Evolution Securities. The group, whose products include Finish, Cillit Bang, Nurofen and Vanish, saw its shares rise 83p to 3445p as Evo's Chas Manso de Zuniga upped the stock to a "buy" from "add". The analyst said Reckitt continued to deliver "regardless of concerns over competitive intensity in the core business" adding the prospects for the year would be as good as 2009.

A solid trading update helped put the wind beneath Kingfisher's wings. The group, which owns DIY store B&Q, rose 4.2p to 217.4p after a trading update said full-year profits would come in slightly ahead of forecasts. The management added that despite bad weather; cost cutting and sourcing its goods from cheaper margins would bring in the slight lift in profits. Analysts at Credit Suisse said it was in a position "where it can develop and reveal its medium-term strategy from a position of relative strength".

Worst of the day was publishing group Reed Elsevier, which put out its full year results. The group's profits were up 1 per cent at constant currencies to £1.75bn in a year when parts of the business has been hit by the recession and the chief executive had departed just eight months after taking on the role. Shares in the group retreated 7.3p to 486.2p.

Reed overtook BT Group, which had stumbled to the foot of the index before lunch after a downgrade by Standard & Poor's. The agency reduced its debt rating on the telecoms giant by one notch to BBB-, putting it just one level above junk. The stock fell 1.4p to close down at 115.8p, the lowest since July. It was also brought low by a bearish note from UBS. The Swiss analyst fears the uncertainty around the group's announcement that the Pension Regulator had serious concerns over its plan to sort out the pension black hole could cause problems, adding: "If it were to mean faster pension paydown [it would] reduce cash yield."

On the second tier, Halfords Group had its pedal to the metal as it revved 47.2p, or 12 per cent, higher to 438.9p. The acceleration came after the group announced it had expanded its operations to servicing cars, buying Nationwide Autocentres for £73.2m. The stock was helped up as analysts backed the deal.

Shares were soaring in VT Group after it sent suitor Babcock International away with a flea in its ear. VT said that the offer valued at between 680p to 715p per share was a "small improvement" on the previous 633.9p, but it wants 800p. The shares rose 38.5p to 660p.

On the downward spiral, investors were taking their chips off the table in bookies Ladbrokes. The shares gave up 5.5p to 151.1p after full year profits fell 28 per cent to £191.3m. It blamed the recession and unfavourable Footsie results. The company, which is still on the lookout for a new chief executive after Chris Bell announced he was to quit the group, said that so far the year had not been kind with horse races and football matches abandoned due to the poor weather conditions.

On Aim, Cove Energy, run by John Craven, stormed higher. It lifted 70 per cent, or 16.5p to 40p after a "significant discovery" off the east coast of Africa.

Also up on the growth market was SpaceandPeople, the marketing and media group whose clients include Audi and Smirnoff, on strong results, closing up 23p to 75p.

Start your day with The Independent, sign up for daily news emails
News
election 2015The 10 best quotes of the campaign
News
A caravan being used as a polling station in Ford near Salisbury, during the 2010 election
election 2015The Independent's guide to get you through polling day
News
people
Voices
David Blunkett joins the Labour candidate for Redcar Anna Turley on a campaigning visit last month
voicesWhat I learnt from my years in government, by the former Home Secretary David Blunkett
ebooks
ebooksA celebration of British elections
  • Get to the point
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Ashdown Group: Editor-in-chief - Financial Services - City, London

£60000 - £70000 per annum + benefits : Ashdown Group: A highly successful, glo...

Ashdown Group: Junior Application Support Analyst - Fluent German Speaker

£25000 - £30000 per annum + benefits: Ashdown Group: A global leader operating...

Guru Careers: Management Accountant

£27 - 35k + Bonus + Benefits: Guru Careers: A Management Accountant is needed ...

Guru Careers: Project Manager / Business Analyst

£40-50k + Benefits.: Guru Careers: A Project Manager / Business Analyst is nee...

Day In a Page

General Election 2015: ‘We will not sit down with Nicola Sturgeon’, says Ed Balls

'We will not sit down with Nicola Sturgeon'

In an exclusive interview, Ed Balls says he won't negotiate his first Budget with SNP MPs - even if Labour need their votes to secure its passage
VE Day 70th anniversary: How ordinary Britons celebrated the end of war in Europe

How ordinary Britons celebrated VE Day

Our perception of VE Day usually involves crowds of giddy Britons casting off the shackles of war with gay abandon. The truth was more nuanced
They came in with William Caxton's printing press, but typefaces still matter in the digital age

Typefaces still matter in the digital age

A new typeface once took years to create, now thousands are available at the click of a drop-down menu. So why do most of us still rely on the old classics, asks Meg Carter?
Discovery of 'missing link' between the two main life-forms on Earth could explain evolution of animals, say scientists

'Missing link' between Earth's two life-forms found

New microbial species tells us something about our dark past, say scientists
The Pan Am Experience is a 'flight' back to the 1970s that never takes off - at least, not literally

Pan Am Experience: A 'flight' back to the 70s

Tim Walker checks in and checks out a four-hour journey with a difference
Humans aren't alone in indulging in politics - it's everywhere in the animal world

Humans aren't alone in indulging in politics

Voting, mutual back-scratching, coups and charismatic leaders - it's everywhere in the animal world
Crisp sales are in decline - but this tasty trivia might tempt back the turncoats

Crisp sales are in decline

As a nation we're filling up on popcorn and pitta chips and forsaking their potato-based predecessors
Ronald McDonald the muse? Why Banksy, Ron English and Keith Coventry are lovin' Maccy D's

Ronald McDonald the muse

A new wave of artists is taking inspiration from the fast food chain
13 best picnic blankets

13 best picnic blankets

Dine al fresco without the grass stains and damp bottoms with something from our pick of picnic rugs
Barcelona 3 Bayern Munich 0 player ratings: Lionel Messi scores twice - but does he score highest in our ratings?

Barcelona vs Bayern Munich player ratings

Lionel Messi scores twice - but does he score highest in our ratings?
Martin Guptill: Explosive New Zealand batsman who sets the range for Kiwis' big guns

Explosive batsman who sets the range for Kiwis' big guns

Martin Guptill has smashed early runs for Derbyshire and tells Richard Edwards to expect more from the 'freakish' Brendon McCullum and his buoyant team during their tour of England
General Election 2015: Ed Miliband's unlikely journey from hapless geek to heart-throb

Miliband's unlikely journey from hapless geek to heart-throb

He was meant to be Labour's biggest handicap - but has become almost an asset
General Election 2015: A guide to the smaller parties, from the the National Health Action Party to the Church of the Militant Elvis Party

On the margins

From Militant Elvis to Women's Equality: a guide to the underdogs standing in the election
Amr Darrag: Ex-Muslim Brotherhood minister in exile still believes Egypt's military regime can be replaced with 'moderate' Islamic rule

'This is the battle of young Egypt for the future of our country'

Ex-Muslim Brotherhood minister Amr Darrag still believes the opposition can rid Egypt of its military regime and replace it with 'moderate' Islamic rule, he tells Robert Fisk
Why patients must rely less on doctors: Improving our own health is the 'blockbuster drug of the century'

Why patients must rely less on doctors

Improving our own health is the 'blockbuster drug of the century'